These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16388521)

  • 21. Phenoxodiol treatment alters the subsequent response of ENOX2 (tNOX) and growth of hela cells to paclitaxel and cisplatin.
    Morré DJ; McClain N; Wu LY; Kelly G; Morré DM
    Mol Biotechnol; 2009 May; 42(1):100-9. PubMed ID: 19156549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients.
    Flick MB; O'Malley D; Rutherford T; Rodov S; Kamsteeg M; Hao XY; Schwartz P; Kacinski BM; Mor G
    J Soc Gynecol Investig; 2004 May; 11(4):252-9. PubMed ID: 15120700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenoxodiol inhibits growth of metastatic prostate cancer cells.
    Aguero MF; Venero M; Brown DM; Smulson ME; Espinoza LA
    Prostate; 2010 Aug; 70(11):1211-21. PubMed ID: 20564423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460.
    Ferreira CG; Span SW; Peters GJ; Kruyt FA; Giaccone G
    Cancer Res; 2000 Dec; 60(24):7133-41. PubMed ID: 11156422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment with gemcitabine and TRA-8 anti-death receptor-5 mAb reduces pancreatic adenocarcinoma cell viability in vitro and growth in vivo.
    DeRosier LC; Huang ZQ; Sellers JC; Buchsbaum DJ; Vickers SM
    J Gastrointest Surg; 2006 Nov; 10(9):1291-300; discussion 1300. PubMed ID: 17114015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.
    Kawaguchi H; Terai Y; Tanabe A; Sasaki H; Takai M; Fujiwara S; Ashihara K; Tanaka Y; Tanaka T; Tsunetoh S; Kanemura M; Ohmichi M
    J Ovarian Res; 2014 Apr; 7():38. PubMed ID: 24713296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway.
    Sun Q; Zheng X; Zhang L; Yu J
    Clin Cancer Res; 2011 Apr; 17(8):2361-72. PubMed ID: 21242120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenoxodiol: pharmacology and clinical experience in cancer monotherapy and in combination with chemotherapeutic drugs.
    Silasi DA; Alvero AB; Rutherford TJ; Brown D; Mor G
    Expert Opin Pharmacother; 2009 Apr; 10(6):1059-67. PubMed ID: 19364253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin and epithelial ovarian cancer therapeutics.
    Patel S; Kumar L; Singh N
    Cell Oncol (Dordr); 2015 Oct; 38(5):365-75. PubMed ID: 26266765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer.
    Hashim YM; Vangveravong S; Sankpal NV; Binder PS; Liu J; Goedegebuure SP; Mach RH; Spitzer D; Hawkins WG
    J Exp Clin Cancer Res; 2017 Jan; 36(1):14. PubMed ID: 28095907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combinatorial treatment of CD95L and gemcitabine in pancreatic cancer cells induces apoptotic and RIP1-mediated necroptotic cell death network.
    Pietkiewicz S; Eils R; Krammer PH; Giese N; Lavrik IN
    Exp Cell Res; 2015 Nov; 339(1):1-9. PubMed ID: 26453936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.
    Siena L; Pace E; Ferraro M; Di Sano C; Melis M; Profita M; Spatafora M; Gjomarkaj M
    Immunology; 2014 Feb; 141(2):242-55. PubMed ID: 24128051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted activation of Stat3 in combination with paclitaxel results in increased apoptosis in epithelial ovarian cancer cells and a reduced tumour burden.
    Li H; Qian Y; Wang X; Pi R; Zhao X; Wei X
    Cell Prolif; 2020 Jan; 53(1):e12719. PubMed ID: 31778258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis.
    Schniewind B; Christgen M; Kurdow R; Haye S; Kremer B; Kalthoff H; Ungefroren H
    Int J Cancer; 2004 Mar; 109(2):182-8. PubMed ID: 14750167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caspase activation is required for gemcitabine activity in multiple myeloma cell lines.
    Nabhan C; Gajria D; Krett NL; Gandhi V; Ghias K; Rosen ST
    Mol Cancer Ther; 2002 Nov; 1(13):1221-7. PubMed ID: 12479703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and daunorubicin by induction of both necrosis and apoptosis.
    Gervasoni JE; Hindenburg AA; Vezeridis MP; Schulze S; Wanebo HJ; Mehta S
    Anticancer Res; 2004; 24(5A):2617-26. PubMed ID: 15517865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenoxodiol Increases Cisplatin Sensitivity in Ovarian Clear Cancer Cells Through XIAP Down-regulation and Autophagy Inhibition.
    Miyamoto M; Takano M; Aoyama T; Soyama H; Ishibashi H; Kato K; Iwahashi H; Takasaki K; Kuwahara M; Matuura H; Sakamoto T; Yoshikawa T; Furuya K
    Anticancer Res; 2018 Jan; 38(1):301-306. PubMed ID: 29277787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells.
    Kim KH; Xie Y; Tytler EM; Woessner R; Mor G; Alvero AB
    J Transl Med; 2009 Jul; 7():63. PubMed ID: 19619321
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin.
    Witham J; Valenti MR; De-Haven-Brandon AK; Vidot S; Eccles SA; Kaye SB; Richardson A
    Clin Cancer Res; 2007 Dec; 13(23):7191-8. PubMed ID: 18056200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cells.
    Christgen M; Schniewind B; Jueschke A; Ungefroren H; Kalthoff H
    Cancer Lett; 2005 Sep; 227(2):193-200. PubMed ID: 16112422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.